Genpharmasec Limited held a separate Independent Directors meeting on March 24, 2026, per Schedule IV of Companies Act, 2013.
Directors reviewed performance of Non-Independent Directors, the Board, and the Chairperson during the 30-minute meeting.
The meeting also assessed quality and timeliness of information flow between management and the Board of Directors.